Astellas Pharma (OTCPK:ALPM.Y) 2026 R&D Day March 30, 2026 08:00 PM ET Company ParticipantsHidemaru Yamaguchi - Managing DirectorNaoki Okamura - President and CEONobuko Kato - Chief Communications and IR OfficerTadaaki Taniguchi - Chief Research and Development OfficerConference Call ParticipantsFumiyoshi Sakai - AnalystHiroyuki Matsubara - Equity Research AnalystMiki Sogi - VP and Senior Research AnalystNobuaki Sawada - AnalystSeiji Wakao - Senior AnalystShinichiro Muraoka - AnalystSteve Barker - Senior Eq ...